NCT05085639View on ClinicalTrials.gov

GLS-5310 Vaccine in Healthy Volunteers for the Prevention of SARS-CoV-2 (COVID-19)

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

December 31, 2022

Conditions
Covid19Healthy
Interventions
BIOLOGICAL

GLS-5130

GLS-5310 DNA plasmid vaccine

BIOLOGICAL

Placebo

Placebo

Trial Locations (2)

00909

Clinical Research Puerto Rico, San Juan

00963

University of Puerto Rico, San Juan

Sponsors
All Listed Sponsors
lead

GeneOne Life Science, Inc.

INDUSTRY

NCT05085639 - GLS-5310 Vaccine in Healthy Volunteers for the Prevention of SARS-CoV-2 (COVID-19) | Biotech Hunter | Biotech Hunter